Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 258-266, 2019.
Artículo
en Coreano
| WPRIM (Pacífico Occidental)
| ID: wpr-761568
Biblioteca responsable:
WPRO
ABSTRACT
Improved management of chronic hepatitis B patients with oral nucleos(t)ide analogues has increased the number of these patients who are getting older and have other accompanying comorbidities. These comorbidities frequently require various immunosuppression treatments and/or cytotoxic chemotherapy. Not only the patients who are positive for HBsAg, but also the patients who are positive for isolated anti-HBc are at risk for hepatitis B reactivation during immunosuppression. Prophylactic antiviral treatment with oral nucleos(t)ide analogues with high genetic barriers can decrease the risks of HBV reactivation, HBV reactivation-associated hepatitis, and mortality in these patients. It is crucial to screen HBV markers in all of the patients who have to undergo immunosuppression, be administered prophylactic antiviral treatment in the high risk groups, and be monitored for HBV reactivation during and after immunosuppression and/or cytotoxic chemotherapy. This study summarizes the recommendations from the recently updated guidelines from Korea, United States, and Europe.
Texto completo:
Disponible
Contexto en salud:
ODS3 - Salud y Bienestar
/
ODS3 - Meta 3.3 Poner fin a las enfermedades desatendidas y detener enfermedades transmisibles
/
ODS3 - Meta 3.4 Reducir las muertes prematuras por enfermedades no transmisibles
Problema de salud:
Meta 3.3: Poner fin a las enfermedades desatendidas y detener enfermedades transmisibles
/
Hepatitis
/
Enfermedades del Sistema Digestivo
Base de datos:
WPRIM (Pacífico Occidental)
Asunto principal:
Estados Unidos
/
Comorbilidad
/
Mortalidad
/
Terapia de Inmunosupresión
/
Hepatitis B Crónica
/
Quimioterapia
/
Europa (Continente)
/
Hepatitis
/
Hepatitis B
/
Antígenos de Superficie de la Hepatitis B
Tipo de estudio:
Guía de práctica clínica
/
Estudio pronóstico
Límite:
Humanos
País/Región como asunto:
America del Norte
/
Asia
/
Europa
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2019
Tipo del documento:
Artículo